Skip to Content

Loading...
The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models.

Roche Personalised Healthcare – our mission

The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models.

Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines.

These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’.

At Roche, ‘Personalised Healthcare’ is at the core of our business strategy.

Our expanding knowledge and understanding of disease mechanisms combined with our molecular biology and technology expertise, are leading us to more targeted therapies, and clinically differentiated products.

Already, we have applied world-class, top level science across the entire value chain to benefit the patient. Treatments for breast and gastric cancer, hepatitis B and hepatitis C are early successes.

Kiyotaka Hirose

Take for example, Kiyotaka Hirose who, as part of the Personalised Healthcare approach, was receiving a targeted treatment to fight his infection with the hepatitis C virus.

Hirose: Life was wonderful; I truly enjoyed playing the piano. But then I received the diagnosis that I was infected with the hepatitis C virus. First I lost all hope. But in discussions with my doctor I gained new optimism. Based on my test results he recommended treatment for seven months.

Speaker: Tests offered by Roche Diagnostics provide detailed information on the quantity and sub-type of the hepatitis C virus. With this information the physician could personalise the treatment of Kiyotaka Hirose for 28 weeks instead of standard therapy for 48 weeks.

Hirose: I regained strength and fully enjoy piano playing and life.

Value of Personalised Healthcare

Clearly, the value of the ‘Personalised Healthcare’ approach is rooted in positive outcomes for the patient – saving lives and improving the quality of life.

But other stakeholders benefit as well.

  • Physicians realise easier decision-making, and better prediction of treatment outcome.
  • Payers and reimbursers see the optimised use of resources and the potential reduction of co-treatments for side effects.
  • And regulators and policymakers find a stronger basis for the development of treatment guidelines.

Simply stated, there is no company in the world in a better position to make this approach a reality.

Personalised Healthcare

Overview

Related Topics

Roche Personalised Healthcare – our mission|The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Roche Personalised Healthcare – our structure|Roche is uniquely positioned to make Personalised Healthcare a reality. Its structure affords access to a broad range of Diagnostic and Pharma technologies and capabilities to systematically pursue this approach across the entire value chain. Roche Personalised Healthcare – our achievements|‘Personalised Healthcare’ goes beyond just companion diagnostics. Today, Roche is already offering more precise diagnosis and targeted treatments. Our accomplishments are many and the pipeline is full. Personalised Healthcare - example Hepatitis|Over 550 million people worldwide are infected with hepatitis B or C. Roche not only sells the standard treatment for chronic hepatitis C, but with diagnostic tests, enables clinicians to decide the individual length of treatment and the drug dosage. The perspective of hepatitis C patient Kiyotaka Hirose (Japan)|Apart from his business life at Chugai, Japan, playing the large concert piano at professional level is the leisure time passion of Kiyotaka Hirose. Unfortunately, without any warning, Mr. Hirose was confronted with a severe diagnosis in 2003. New therapies for patients|Current treatment approaches for hepatitis C infections: Testing, treating and adjusting therapy to fit patients’ needs – a ‘real-life’ example of the benefits of Roche Personalised Healthcare. Personalised Healthcare - example Lung Cancer|Non-small cell lung cancer (NSCLC) is the world’s number one cause of cancer related death, the most common form being adenocarcinoma. Impact on laboratory medicine today and tomorrow|In 2011 important progress was seen in making the strategy of Personalised Healthcare a reality. Professor Dr. Phillipp von Landenberg, head of the institute of laboratory medicine at the Solothurn hospitals in Olten, Switzerland, shares his views on the implications of this approach. Personalised Healthcare means fitting treatments to different groups of patients|The future of medicine lies in customisation of this kind and our vision of Personalised Healthcare is becoming reality. Why PHC? How does Roche make it a reality? Where do we stand today? And what do some external experts think about PHC? These questions are covered here. No longer treating different conditions identically|As part of the 'Business and Science in Dialogue' series, an information forum entitled ‘Personalised Healthcare – the Custom-Made Pill?’ was held at the Congress Center Basel. Personalised Healthcare – in brief|Conventionally practiced healthcare has not been as effective as it could be. Too many patients receive treatments that are not advantageous for their particular disease scenario. Personalised Healthcare – Position Paper|Roche, as an innovation-driven global healthcare company, is pioneering PHC solutions with passion. Roche is convinced that PHC is key to delivering further improvements in the practice of medicine.